NEW YORK (TheStreet) -- BlackBerry's (BBRY) board of directors may be exploring the possibility of selling the company, but the company is still announcing and creating new phones. Early this morning, Blackberry announced what could be its final smartphone - the Z30.
The Z30 is the first BlackBerry approaching "phablet" size, as it boasts a 5-inch Super AMOLED display (1280 by 720 pixels). The new phone also sports a "1.7 GHz processor (dual-core Qualcomm (QCOM) Snapdragon S4) with quad- core graphics", 2 GB of RAM, 16 GB of internal storage and stereo speakers.
BlackBerry's latest offering includes the company's newly improved antenna technology. BlackBerry has always been in the forefront of cellular antenna design. The cameras are similar to what has been offered in the BlackBerry Z10 - 8 MP on the back and 2 MP up front.
Also new in the Z30 is the operating system. It's the first BlackBerry device to come with OS 10.2. The company says 10.2 "includes hundreds of refinements plus many new features that help you be more productive". Slightly less vague is the claim that the new operating software in combination with a (non-removable) 2880 mAh battery pack will be able to provide as much as 25 hours of "mixed use".
OS 10.2 improves upon the BlackBerry Hub system which now includes a "Priority Hub". The new software still gathers all of your calls, email, messages and social networking into one location and now adds a listing for priority messages.
BlackBerry has released a video promoting the Z30 and its best features. You can watch it here.
While BlackBerry says the new phone will become available beginning next week, it means available in the UK and Middle East markets. The Waterloo, Ontario-based company said the rest of the world should expect "pre-holiday season" release dates. No official carriers were named and no actual prices were announced in the corporate press release.
BlackBerry shares were higher on back of the news, gaining 1%! to $10.66.
Written by Gary Krakow in New York.
To submit a news tip, send an email to tips@thestreet.com.
Top 5 Life Sciences Companies To Invest In Right Now: bluebird bio Inc (BLUE)
bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. Gene therapy seeks to introduce a functional copy of the defective gene into a patient�� own cells, a process called gene transfer. Through gene transfer, a functional copy of the mutated gene is delivered to the patient�� cells, thereby correcting the underlying genetic defect that causes aberrant gene expression. As of December 31, 2012, the Company is conducting a Phase I/II clinical study in France evaluating an earlier generation of its LentiGlobin vector for the treatment of �-thalassemia major and SCD. Initial proof-of-concept data from this study were published in Nature. During the year ended December 31, 2013, the Company plans to initiate an extension of this study under a revised protocol for LentiGlobin, which the Company refers to as the HGB-205 Study. The Company also plans o initiate a second Phase I/II clinical program in the United States for LentiGlobin, which the Company refers to as the HGB-204 Study, for �-thalassemia major. In March 2013, the Company entered into a strategic collaboration with Celgene Corporation, or Celgene, to discover, develop and commercialize, disease-altering gene therapies in oncology.
Its gene therapy platform is based on viral vectors that utilize a modified, non-replicating version of the Human Immunodeficiency Virus Type 1 (HIV-1) virus, that has been stripped of all of the components required for it to self-replicate and infect additional cells. The HIV-1 virus is part of the lentivirus family of viruses, as a result of which the Company refer to its vectors as lentiviral vectors. Its lentiviral vectors are used to introduce a functional copy of a gene to the patient�� own isolated blood stem cells, called hematopoietic stem cells (HSCs), which reside in a patient�� bone marrow and are capable of differentiating int! o a wide range of cell types. HSCs are dividing cells, thus its approach allows for sustained expression of the modified gene as the Company is able to take advantage of a lifetime of replication of the gene-modified HSCs. Additionally, the Company has developed a cell-based vector manufacturing process that is both reproducible and scalable.
Adrenoleukodystrophy
Adrenoleukodystrophy is a rare X-linked, inherited, neurological disorder that is often fatal. ALD is caused by mutations in the ABCD1 gene which encodes for a protein called the ALD protein (ALDP), which plays a critical role in the breakdown and metabolism of long-chain fatty acids (VLCFA). Without functional ALDP, VLCFA accumulate in cells including neural cells in which they cause damage to the myelin sheath, a protective and insulating membrane that surrounds nerve cells in the brain. This damage can result in decreased motor coordination and function, visual and hearing disturbances, the loss of cognitive function, dementia, seizures, adrenal dysfunction and other complications, including death. ALD is divided into various sub-segments with three main phenotypes that impact brain function: CCALD (Childhood cerebral adrenoleukodystrophy, AMN (Adrenomyeloneuropathy) and ACALD (Adult Cerebral ALD).
�-thalassemia
�-thalassemia is a rare hereditary blood disorder caused by a genetic abnormality of the �-globin gene resulting in defective red blood cells (RBCs). Genetic mutations cause the absence or reduced production of the beta chains of hemoglobin, or �-globin, thereby preventing the proper formation of hemoglobin A, which normally accounts for greater than 95% of the hemoglobin in the blood of adults. Hemoglobin is an iron-containing protein in the blood that carries oxygen from the respiratory organs to the rest of the body. Hemoglobin A consists of four chains-two chains each of a-globin and �-globin. Normally existing at an approximate 1:1 ratio, genetic mutations that impair t! he produc! tion of �-globin can lead to a relative excess of a-globin, premature death of red blood cells. The clinical implications of the a-globin/�-globin imbalance are two-fold: first, patients lack sufficient RBCs and hemoglobin to effectively transport oxygen throughout the body and can become severely anemic; and second, the shortened life span and ineffective production of RBCs can lead to other complications such as splenomegaly, marrow expansion, bone deformities, and iron overload in organs.
Sickle cell disease
Sickle cell disease (SCD) is a hereditary blood disorder resulting from a mutation in the �-globin gene that causes polymerization of hemoglobin proteins and abnormal red blood cell function. The disease is characterized by anemia, vaso-occlusive pain crisis (a common complication of SCD in which there is severe pain due to obstructed blood flow in the bones, joints, lungs, liver, spleen, kidney, eye, or central nervous system), infections, stroke, overall poor life and early death in a subset of patients. Under low-oxygen conditions, which are exacerbated by the red blood cell abnormalities, the mutant hemoglobin aggregates causing the RBCs to take on a sickle shape (sickle cells), which causes them to aggregate and obstruct small blood vessels, thereby restricting blood flow to organs resulting in pain, cell death and organ damage. If oxygen levels are restored, the hemoglobin can disaggregate and the RBCs return to their normal shape, but over time, the sickling damages the cell membrane and the cells fail to return to the normal shape even in high-oxygen conditions.
Advisors' Opinion:- [By Jay Silverman]
Some of the biggest leaders in that field, and there have been dozens in fields, if not more this year, such as Bluebird (BLUE) and Stemline Therapeutics (STML) and have all pulled back to significantly lower levels; even below, in Bluebird's case, the price that had actually opened up as an IPO, even though it's above its IPO price.
- [By Garrett Cook]
Bluebird Bio (NASDAQ: BLUE) shares shot up 33.61 percent to $34.86 following the presentation of positive data on LentiGlobin BB305 at the European Hematology Association (EHA).
- [By Garrett Cook]
Bluebird Bio (NASDAQ: BLUE) shares shot up 34.74 percent to $35.15 following the presentation of positive data on LentiGlobin BB305 at the European Hematology Association (EHA).
- [By David Williamson]
In this video, health-care analyst David Williamson takes a look at the tremendous success of the�Bluebird Bio (NASDAQ: BLUE ) �IPO. The company increased the size of its initial public offering, and priced shares at $17 -- above the top end of its range -- but that still couldn't contain investor appetite for this stock. Shares shot up 50% on the opening day of trading, and have remained there.
Top Tech Companies To Buy Right Now: Sourcefire Inc.(FIRE)
Sourcefire, Inc. provides intelligent Cybersecurity technologies to commercial enterprises and government agencies worldwide. The company?s network security products include Sourcefire appliances for detecting, blocking, and analyzing network traffic; Sourcefire IPS to examine network packets for threats; Sourcefire NGIPS to discover the characteristics and vulnerabilities of computing devices communicating on a network; Sourcefire NGIPS with Application Control to provide granular control of applications; Sourcefire NGFW that includes application control and firewall capabilities; and Sourcefire SSL Appliance, which decrypts SSL traffic for inspection by network security appliances. It also offers FireAMP, a malware protection solution that uses data analytics to discover, understand, and block malware outbreaks; and Sourcefire Defense Center that provides application programming interfaces to interoperate third-party systems, such as firewalls, routers, log management, security information event management, trouble ticketing, patch management systems, and other technologies. In addition, the company provides Sourcefire Virtual Appliance, an application to inspect communications between different virtual machines; Sourcefire Virtual Defense Center, which provides central management, event analysis, and reporting services; Snort, a traffic inspection engine used in intrusion prevention system; ClamAV, an open source anti-malware product; and Razorback, an open-source project that addresses threat detection and protection. Further, it provides customer support, professional, and education and certification services. The company serves financial institutions, defense contractors, health care providers, IT companies, telecommunication companies, and retailers, as well as national, state, and local government agencies. Sourcefire, Inc. was founded in 2001 and is headquartered in Columbia, Maryland.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of Sourcefire (NASDAQ: FIRE ) soared a whopping 28% today after tech gorilla Cisco Systems (NASDAQ: CSCO ) agreed to acquire the cybersecurity specialist for $2.7 billion.�
- [By Evan Niu, CFA]
What: Shares of Sourcefire (NASDAQ: FIRE ) were on fire today, enjoying gains as great as 15%, after the company reported earnings.
So what: Revenue in the first quarter came in at $56.2 million, which resulted in non-GAAP earnings per share of $0.11. Those figures represent misses on both top and bottom lines, as analysts were expecting sales of $57.4 million and adjusted earnings of $0.12 per share.
- [By Holly LaFon]
Sourcefire Inc. (3.0%) (FIRE - $75.92 - NASDAQ) (FIRE), based in Columbia, MD, provides cybersecurity technologies ��both hardware and software ��to enterprises and government agencies worldwide. On July 23, 2013, Cisco announced it would acquire Sourcefire for $76.00 cash per share. The $2.7 billion merger currently has all required regulatory approvals. The shareholder vote is scheduled on October 7, and the deal should close shortly thereafter.
Top Tech Companies To Buy Right Now: Oracle Corporation(ORCL)
Oracle Corporation, an enterprise software company, develops, manufactures, markets, distributes, and services database and middleware software, applications software, and hardware systems worldwide. It licenses of database and middleware software, including database management software, application server software, service-oriented architecture and business process management software, data integration software, business intelligence software, identity and access management software, content management software, portals and user interaction software, development tools, and Java; and applications software comprising enterprise resource planning, customer relationship management, enterprise performance management, supply chain management, business intelligence applications, enterprise portfolio project management, Web commerce, and industry-specific applications software. The company also offers customers with rights to unspecified software product upgrades and maintenance releases; Internet access to technical content; and Internet and telephone access to technical support personnel. In addition, its hardware systems products consist of computer server and hardware-related software, including the Oracle Solaris Operating System; and storage products, such as tape, disk and networking solutions for open systems and mainframe server environments. Its hardware systems support solutions include software updates for the software components. Further, the company offers consulting solutions in business and IT strategy alignment, enterprise architecture planning and design, initial product implementation and integration, and ongoing product enhancements and upgrades; cloud services, including Oracle Cloud Services and Advanced Customer Services; and education solutions comprising instructor-led, media-based, and Internet-based training in the use of its software and hardware products. The company was founded in 1977 and is headquartered in Redwood Ci ty, California.
Advisors' Opinion:- [By Matt Thalman]
Shares of IBM (NYSE: IBM ) are down 1.3% today, perhaps because of the disappointing fourth-quarter results Oracle (NYSE: ORCL ) posted yesterday. This is especially troubling because, as my colleague Alex Dumortier noted earlier today, the fourth quarter is historically Oracle's best in terms of sales. Investors may be concerned that this slowdown for Oracle will prove a trend for the� whole IT sector, includes Big Blue. Investors have been concerned about IBM growth prospects moving forward. The stock has struggled in 2013, rising only 1.85% year to date to make it the fourth-worst-performing Dow component of the year.
- [By Alex Planes]
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Oracle (NYSE: ORCL ) fit the bill? Let's look at what its recent results tell us about its potential for future gains.
Top Tech Companies To Buy Right Now: Propell Technologies Group Inc (PROP)
Propell Technologies Group, Inc., incorporated on February 04, 2008, offers enhanced oil recovery technology and services. These services are offered through its wholly owned subsidiary Novas Energy USA, Inc., through commercial application of a Plasma-Pulse Technology.
The Company�� technology is designed to be suitable for oil wells as deep as 12,000 feet. Novas�� Plasma-Pulse Treatment is an Enhanced Oil Recovery (EOR) technology and process. The treatment uses no chemicals.
Advisors' Opinion:- [By John Udovich]
Although oil prices ended the year at multi year lows, now would be the time to take a closer look at�small cap gas compression or enhanced oil recovery (EOR) stocks like�Usa Compression Partners LP (NYSE: USAC), CSI Compressco LP (NASDAQ: CCLP) and Propell Technologies Group Inc (OTCBB: PROP) before oil and gas prices inevitably rise again. To begin with, natural gas compression services are used to transport natural gas and specifically to get�natural gas from low-pressure wells into gathering systems, storage and processing facilities�as well as to maintain production as reservoir pressure declines. Compression services�are also used to extract gas from�unconventional natural gas sources like shale plays. Meanwhile,�so-called enhanced oil recovery or EOR is just a generic term for the techniques used for increasing the amount of crude oil that can be extracted from an oil field with potential methods including steam flood and water flood injection�or hydraulic fracturing�(so-called fracking). Naturally, demand for compression services and EOR technologies would be impacted by oil and gas commodity prices.
Top Tech Companies To Buy Right Now: Intralinks Holdings Inc (IL)
IntraLinks Holdings, Inc. (IntraLinks), incorporated in June 1996, together with its subsidiaries, is a global provider of Software-as-a-Service (SaaS) solutions for securely managing content, exchanging critical business information and collaborating within and among organizations. The Company�� cloud-based solutions enable organizations to control, track, search and exchange time-sensitive information inside and outside the firewall, all within a secure environment. The Company provide services to enterprises and governmental agencies in over 60 countries across a variety of industries, including financial services, pharmaceutical, biotechnology, consumer, energy, industrial, legal, insurance, real estate and technology. The Company sells its solutions directly through an enterprise sales team with industry-specific expertise and indirectly through a customer referral network and channel partners. In April 2013, it acquired MergerID. Concurrently, IntraLinks acquired PE-Nexus LLC.
The Company delivers its solutions through a cloud-based model where they are available on-demand over the Internet using a multi-tenant SaaS architecture in which a single instance of its software serves all of its customers. The Company provides its customers with various services, including access to its cloud-based IntraLinks Platform, access to one or more of its intraLinks exchanges, and related customer support and other services.
The Company competes with Merrill Corporation, RR Donnelley & Sons Company, EMC Corporation and International Business Machines Corp. (IBM).
Advisors' Opinion:- [By Lee Jackson]
IntraLinks Holdings Inc. (NYSE: IL) is a leading global software as a service (SaaS) provider of inter-enterprise content management and collaboration solutions. It recently launched Intralinks DealNexus, the largest global deal marketplace and professional network for qualified mergers and acquisitions (M&A) professionals. Intralinks DealNexus offers a secure and confidential way for dealmakers to find and engage the best buyers or capital partners, and it is used by more than 5,000 private equity firms, corporations, investment banks and advisors to intelligently connect and exchange deal opportunities. Wunderlich rates the company a stock to buy and has a $17 price objective. The consensus target is $12.The stock closed on Friday at $8.61.
- [By Seth Jayson]
IntraLinks Holdings (NYSE: IL ) reported earnings on May 8. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), IntraLinks Holdings beat expectations on revenues and met expectations on earnings per share.
Top Tech Companies To Buy Right Now: Analytica Bio - Energy Corp (ABEC)
Analytica Bio-Energy Corp., formerly Uniwell Electronic Corporation, incorporated on January 12, 2004, is a company with water purification system. The Company was a shell company.
The Company focused on acquiring an active business. In September 2013, the Company changed its name to Analytica Bioenergy, Inc.
Advisors' Opinion:- [By Dan Burrows]
Most importantly, on days when this penny stock did see heavy volume, it tumbled — a classic red flag for the “dump” part of pump-and-dump schemes, which penny stocks are ripe for.
Top Penny Stocks: Analytica Bio-Energy Corp. (ABEC)YTD Performance: 29,300%
52-Week Range: $0.0017 – $0.50
Average Volume (3 months): 9,574
Market Cap: $10.6 million
No comments:
Post a Comment